Avid Bioservices is a dedicated biologics CDMO capable of taking projects from concept to commercialization. The company has manufactured commercial biologics since 2005 and has produced more than 150 commercial batches of drug substance using mammalian cell culture.

From our origins in drug development as a subsidiary of an R&D-based pharma company, to our current year-over-year growth as a profitable commercial biologics manufacturer, Avid is committed to our continued success. We are primed for growth, expanding capacity to meet growing customer demand, and contemplating business segments, lines of services or new service offerings where we feel we could leverage our skills and expertise and the value proposition we have developed in the current business.